208 related articles for article (PubMed ID: 36235242)
21. Trafficking of FoxP3+ regulatory T cells: myths and facts.
Kim CH
Arch Immunol Ther Exp (Warsz); 2007; 55(3):151-9. PubMed ID: 17557143
[TBL] [Abstract][Full Text] [Related]
22. Exploring the role CD163-labeled TAMs and FOXP3-labeled Tregs in different types of breast cancer: Reflections and putative benefits.
Shash LS; M Kamal KA; Abd Raboh NM
Indian J Pathol Microbiol; 2021; 64(1):28-37. PubMed ID: 33433406
[TBL] [Abstract][Full Text] [Related]
23. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
24. Adenosine Generated by Regulatory T Cells Induces CD8
Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
[TBL] [Abstract][Full Text] [Related]
25. From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics.
Bending D; Ono M
Clin Exp Immunol; 2019 Jul; 197(1):14-23. PubMed ID: 30076771
[TBL] [Abstract][Full Text] [Related]
26. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment.
Ma GF; Miao Q; Liu YM; Gao H; Lian JJ; Wang YN; Zeng XQ; Luo TC; Ma LL; Shen ZB; Sun YH; Chen SY
Br J Cancer; 2014 Mar; 110(6):1552-60. PubMed ID: 24548868
[TBL] [Abstract][Full Text] [Related]
27. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells.
McMurchy AN; Gillies J; Allan SE; Passerini L; Gambineri E; Roncarolo MG; Bacchetta R; Levings MK
J Allergy Clin Immunol; 2010 Dec; 126(6):1242-51. PubMed ID: 21036387
[TBL] [Abstract][Full Text] [Related]
28. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
[TBL] [Abstract][Full Text] [Related]
29. CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer.
Zhou S; Shen Z; Wang Y; Ma H; Xu S; Qin J; Chen L; Tao H; Zhen Z; Chen G; Zhang Z; Li R; Xiao H; Zhong C; Yang Y; Liang C
PLoS One; 2013; 8(9):e74430. PubMed ID: 24040244
[TBL] [Abstract][Full Text] [Related]
30. Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas.
Won KY; Kim HS; Sung JY; Kim GY; Lee J; Park YK; Kim YW; Suh JH; Lim SJ
Pathol Res Pract; 2013 Dec; 209(12):767-73. PubMed ID: 24071443
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of Helios in Foxp3
Yu WQ; Ji NF; Gu CJ; Wang YL; Huang M; Zhang MS
Dis Markers; 2021; 2021():5574472. PubMed ID: 34257746
[TBL] [Abstract][Full Text] [Related]
32. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
33. Foxp3 as a marker of tolerance induction versus rejection.
Zhang GY; Hu M; Wang YM; Alexander SI
Curr Opin Organ Transplant; 2009 Feb; 14(1):40-5. PubMed ID: 19337145
[TBL] [Abstract][Full Text] [Related]
34. CD30 discriminates heat shock protein 60-induced FOXP3+ CD4+ T cells with a regulatory phenotype.
de Kleer I; Vercoulen Y; Klein M; Meerding J; Albani S; van der Zee R; Sawitzki B; Hamann A; Kuis W; Prakken B
J Immunol; 2010 Aug; 185(4):2071-9. PubMed ID: 20631311
[TBL] [Abstract][Full Text] [Related]
35. Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach.
Yoshii M; Tanaka H; Ohira M; Muguruma K; Iwauchi T; Lee T; Sakurai K; Kubo N; Yashiro M; Sawada T; Hirakawa K
Br J Cancer; 2012 May; 106(10):1668-74. PubMed ID: 22569001
[TBL] [Abstract][Full Text] [Related]
36. Higher densities of Foxp3
Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells.
Sadlon TJ; Wilkinson BG; Pederson S; Brown CY; Bresatz S; Gargett T; Melville EL; Peng K; D'Andrea RJ; Glonek GG; Goodall GJ; Zola H; Shannon MF; Barry SC
J Immunol; 2010 Jul; 185(2):1071-81. PubMed ID: 20554955
[TBL] [Abstract][Full Text] [Related]
38. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
Wolf D; Wolf AM; Rumpold H; Fiegl H; Zeimet AG; Muller-Holzner E; Deibl M; Gastl G; Gunsilius E; Marth C
Clin Cancer Res; 2005 Dec; 11(23):8326-31. PubMed ID: 16322292
[TBL] [Abstract][Full Text] [Related]
39. FOXP3 expression and nodal metastasis of breast cancer.
Gökmen-Polar Y; Thorat MA; Sojitra P; Saxena R; Badve S
Cell Oncol (Dordr); 2013 Oct; 36(5):405-9. PubMed ID: 23996727
[TBL] [Abstract][Full Text] [Related]
40. Human FOXP3 and cancer.
Martin F; Ladoire S; Mignot G; Apetoh L; Ghiringhelli F
Oncogene; 2010 Jul; 29(29):4121-9. PubMed ID: 20498631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
